The trial involved 32,449 participants, about 20 percent of whom were age 65 and older and about 60 percent of whom had comorbidities linked to an increased risk for progression of severe COVID-19. The vaccine was well tolerated, and its efficacy was consistent among all age and ethnicity groups.
AstraZeneca’s vaccine is authorized for emergency use in dozens of countries. The drugmaker is expected to apply for FDA emergency approval within weeks.
The U.S. has ordered 300 million doses of AstraZeneca’s vaccine.
More articles on pharmacy:
Federal judge blocks HHS final rule on 340B program
US will surpass goal of 100M vaccinations in 100 days, Biden says
West Virginia pharmacist sentenced to more than 11 years for wire fraud, money laundering
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
